NCT04901949

Brief Summary

In obese (OB) patients, the presence of an increased inflammatory state in the body due to the increase in abdominal adipose tissue and increase in the frequency of gallstones and lipid levels are expected to increase the development of acute pancreatitis (AP). The effect of obesity on the clinical course of acute pancreatitis has much been attracted the attention of researchers. The aim of this study is to evaluate whether the prevalence and severity of AP, as well as Balthazar tomographic scoring, differs in BMI groups (normal, overweight, obese).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,334

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 3, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

May 26, 2021

Completed
Last Updated

May 26, 2021

Status Verified

May 1, 2021

Enrollment Period

6 months

First QC Date

May 3, 2021

Last Update Submit

May 20, 2021

Conditions

Keywords

Acute pancreatitisObesityBody Mass IndexRevised Atlanta ScoringBalthazar Scoring

Outcome Measures

Primary Outcomes (2)

  • The course of acute pancreatitis (mild, moderate, and severe) will be evaluated in patients with different body mass index groups.

    The course of acute pancreatitis is defined as mild (no organ insufficiency and local complications), moderate (presence of local complications +/- transient organ insufficiency less than \<48h), and severe (permanent organ insufficiency longer than 48h) according to the revised Atlanta scoring. Body mass index is calculated by dividing the weight of a patient (as a kilogram) by the height (as a square meter). Normal weighted patients form Group 1 (≤24,9 kg/m2), overweighted patients form Group 2 (25-30 kg/m2), and obese patients form Group 3 (≥30,1 kg/m2).

    Within a month

  • Efficacy of acute pancreatitis tomographic scoring (Balthazar) in different body mass index groups

    Does the course of acute pancreatitis in the body mass index groups (Group 1, 2, and 3) show parallelism with the tomographic scoring? Whether tomographic score is successful or not in different body mass index groups?

    Within a month

Secondary Outcomes (5)

  • Hospitalization days of the patients according to body mass index groups?

    Within a month

  • Need for intensive care unit hospitalization

    Within a month

  • Did the patient lose his life due to AP?

    Within a month

  • Whether interventional procedures such as endosonography or endoscopic retrograde cholangiopancreatography are required due to the patient's disease

    Within a month

  • How many times has the patient had an acute pancreatitis attack?

    Through study completion, an average of 1 year

Study Arms (3)

BMI Group 1

If BMI is less than 24,9 kg/m2

BMI Group 2

If BMI is between 25 - 30 kg/m2

BMI group 3

If BMI is more than 30,1 kg/m2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a diagnosis of acute pancreatitis.

You may qualify if:

  • Patients with acute pancreatitis diagnosis according to the revised Atlanta criteria.

You may not qualify if:

  • Patients who sign a treatment rejection form immediately after admission to the hospital and leave the hospital,
  • Psychiatric patients
  • Patients with very poor general conditions will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif University, Gastroenterology Clinic

Istanbul, 34093, Turkey (Türkiye)

Location

Related Publications (3)

  • Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779. Epub 2012 Oct 25.

  • Khatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis. Curr Opin Gastroenterol. 2017 Sep;33(5):374-382. doi: 10.1097/MOG.0000000000000386.

  • Shin KY, Lee WS, Chung DW, Heo J, Jung MK, Tak WY, Kweon YO, Cho CM. Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver. 2011 Sep;5(3):335-9. doi: 10.5009/gnl.2011.5.3.335. Epub 2011 Aug 18.

Related Links

MeSH Terms

Conditions

PancreatitisObesityBody Weight

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ali̇ Tüzün Ince

    Bezmialem Vakif Universitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2021

First Posted

May 26, 2021

Study Start

September 20, 2020

Primary Completion

April 1, 2021

Study Completion

April 30, 2021

Last Updated

May 26, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations